By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



1 North Waukegan Road

North Chicago  Illinois  60064  U.S.A.
Phone: 1-800-255-5162 Fax: n/a


AbbVie (NYSE:ABBV) is a global, research-based biopharmaceutical company formed in 2013 following separation from Abbott Laboratories. The company's mission is to use its expertise, dedicated people and unique approach to innovation to develop and market advanced therapies that address some of the world's most complex and serious diseases. AbbVie employs approximately 25,000 people worldwide and markets medicines in more than 170 countries.

Key Statistics

Ownership: Public

Web Site: AbbVie
Symbol: ABBV


Company News
AbbVie (ABBV) Announces Expiration Of Hart-Scott-Rodino Waiting Period AbbVie's Acquisition Of Pharmacyclics (PCYC) 5/22/2015 6:15:18 AM
AbbVie (ABBV) Announces Offer Consideration For Acquisition Of Pharmacyclics (PCYC) 5/21/2015 8:33:38 AM
Achillion (ACHN), Johnson & Johnson (JNJ) Hammer Out $1 Billion+ Hep C R&D Pact to Compete With Gilead (GILD) and AbbVie (ABBV) 5/19/2015 3:42:55 PM
AbbVie (ABBV) Extends Exchange Offer To Acquire Pharmacyclics (PCYC) 5/18/2015 7:21:50 AM
AbbVie (ABBV) Receives Orphan Drug Designation For HUMIRA (Adalimumab) From The FDA For The Investigational Treatment Of Moderate-To-Severe Hidradenitis Suppurativa (HS) 5/15/2015 10:20:52 AM
AbbVie (ABBV), Johnson & Johnson (JNJ) Floated as Possible Suitors For Freshly Flush Galapagos (GLPG.BR) 5/14/2015 7:04:28 AM
AbbVie (ABBV), Bristol-Myers Squibb (BMY) Drug Delays Blood Cancer Progression 5/14/2015 6:55:12 AM
BioSpace (DHX) Temperature Poll: Will AbbVie (ABBV), Genentech (RHHBY)’s New Cancer Drug Be a Game Changer? 5/13/2015 11:15:01 AM
AbbVie (ABBV) To Present At UBS Global Healthcare Conference 5/13/2015 10:42:55 AM
AbbVie (ABBV)'s Commitment To Gastroenterology And Hepatology Showcased At Digestive Disease Week (DDW) 2015 5/12/2015 10:30:07 AM